JAC Advance Access originally published online on June 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 52, 128-131
© 2003 The British Society for Antimicrobial Chemotherapy
Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO·SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections
1 Clinical Microbiology, Central Hospital, S-351 85 Växjö, Sweden; 2 LEO Pharma, DK-2750 Ballerup, Denmark
Received 27 December 2002; returned 5 January 2003; revised 2 April 2003; accepted 2 April 2003
The antimicrobial resistance profiles, comprising 12 antibiotics, of 2478 isolates of Escherichia coli from the ECO·SENS Project involving women with acute uncomplicated urinary tract infection at 252 community health care centres in 17 countries were determined. Resistance to ampicillin alone (6.3%) and sulfamethoxazole alone (5.4%) were the most common single resistances. Multiple resistance was most common in Spain and least common in Finland. The main associated-resistance profiles involved ampicillin/sulfamethoxazole (8.7%) and ampicillin/sulfamethoxazole/trimethoprim/trimethoprimsulfamethoxazole (6.4%). The most common profile of multiple resistance was ampicillin/sulfamethoxazole/trimethoprim/trimethoprimsulfamethoxazole/nalidixic acid/ciprofloxacin. Twenty-one isolates, half of which came from Spain, were resistant to seven antibiotics or more. Three isolates, one from Spain and two from Portugal, were resistant to nine of the 12 antibiotics investigated.
Keywords: cross-resistance, associated resistance, Escherichia coli
* Corresponding author. Tel: +46-470-587-477; Fax: +46-470-587-455; E-mail: gunnar.kahlmeter{at}ltkronoberg.se
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Sundqvist, P. Geli, D. I. Andersson, M. Sjolund-Karlsson, A. Runehagen, H. Cars, K. Abelson-Storby, O. Cars, and G. Kahlmeter Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use J. Antimicrob. Chemother., November 8, 2009; (2009) dkp387v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sundqvist and G. Kahlmeter 'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections fails J. Antimicrob. Chemother., August 1, 2009; 64(2): 227 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takahashi, T. Muratani, M. Yasuda, S. Takahashi, K. Monden, K. Ishikawa, H. Kiyota, S. Arakawa, T. Matsumoto, H. Shima, et al. Genetic Profiles of Fluoroquinolone-Resistant Escherichia coli Isolates Obtained from Patients with Cystitis: Phylogeny, Virulence Factors, PAIusp Subtypes, and Mutation Patterns J. Clin. Microbiol., March 1, 2009; 47(3): 791 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uzunovic-Kamberovic Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina J. Antimicrob. Chemother., August 1, 2006; 58(2): 344 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Landgren, H. Oden, I. Kuhn, A. Osterlund, and G. Kahlmeter Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries J. Antimicrob. Chemother., June 1, 2005; 55(6): 928 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kahlmeter, P. Menday, and O. Cars Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection J. Antimicrob. Chemother., December 1, 2003; 52(6): 1005 - 1010. [Abstract] [Full Text] [PDF] |
||||

